Novo Nordisk
NVO
#105
Rank
A$269.93 B
Marketcap
A$61.23
Share price
2.31%
Change (1 day)
-20.37%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2026 (TTM): A$33.43 Billion

According to Novo Nordisk's latest financial reports the company's current earnings are A$51.43 Billion. In 2025 the company made an earning of A$30.86 Billion, an increase over its 2024 earnings that were of A$29.03 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$33.43 B8.35%
2025 A$30.86 B6.28%
2024 A$29.03 B28.01%
2023 A$22.68 B57.81%
2022 A$14.37 B5.24%
2021 A$13.65 B12.38%
2020 A$12.15 B13.11%
2019 A$10.74 B-3.45%
2018 A$11.12 B1.88%
2017 A$10.92 B4.3%
2016 A$10.47 B10.32%
2015 A$9.49 B7.47%
2014 A$8.83 B3.4%
2013 A$8.54 B19.09%
2012 A$7.17 B15.58%
2011 A$6.20 B16.58%
2010 A$5.32 B25.66%
2009 A$4.23 B10.68%
2008 A$3.82 B55.82%
2007 A$2.45 B7.02%
2006 A$2.29 B19.05%
2005 A$1.92 B10.55%
2004 A$1.74 B
2002 A$1.15 B-14.39%
2001 A$1.34 B-52.82%
2000 A$2.85 B250%
1999 A$0.81 B31.21%
1998 A$0.62 B34.31%
1997 A$0.46 B11.46%
1996 A$0.41 B9.03%
1995 A$0.38 B-3.15%
1994 A$0.39 B-0.67%
1993 A$0.39 B45.38%
1992 A$0.27 B-13.81%
1991 A$0.31 B37.12%
1990 A$0.23 B-0.79%
1989 A$0.23 B26.2%
1988 A$0.18 B24.97%
1987 A$0.14 B-0.9%
1986 A$0.14 B-7.78%
1985 A$0.16 B24.87%
1984 A$0.12 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$10.25 B-69.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$51.19 B 51.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$11.46 B-66.12%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
A$16.68 B-50.70%๐Ÿ‡บ๐Ÿ‡ธ USA